Wasicek C A, Reichlin M
J Clin Invest. 1982 Apr;69(4):835-43. doi: 10.1172/jci110523.
Among 55 systemic lupus erythematosus patients having antibodies to Ro and/or La, two major groups were distinguished by titration of sera in counterimmunoelectrophoresis. The first group (30 patients) had antibodies to Ro alone. This was associated with a high incidence of antibodies to DNA (77%) and serious renal disease (53%). The second group (23 patients) had antibodies to Ro and La, and this was associated with a lower incidence of antibodies to DNA (30%) and a very low incidence of nephritis (9%). In this group a phenomenon of linkage of anti- Ro and anti-La titers was observed. Additionally two patients with only anti-La were found. Neither had clinically apparent renal disease. Thus, systemic lupus erythematosus patients with anti-Ro fall into two subgroups that differ considerably in their prevalence of anti-DNA and serious renal disease.
在55例抗Ro和/或La抗体阳性的系统性红斑狼疮患者中,通过对流免疫电泳法测定血清滴度,区分出两个主要组。第一组(30例患者)仅抗Ro抗体阳性。这与高频率的抗DNA抗体(77%)和严重肾脏疾病(53%)相关。第二组(23例患者)抗Ro和La抗体均阳性,这与较低频率的抗DNA抗体(30%)和极低频率的肾炎(9%)相关。在该组中观察到抗Ro和抗La滴度的关联现象。此外,发现2例仅抗La抗体阳性患者。二者均无临床明显肾脏疾病。因此,抗Ro抗体阳性的系统性红斑狼疮患者分为两个亚组,其抗DNA抗体频率和严重肾脏疾病有显著差异。